BGC Partners appoints Arthur Mbanefo to Board of Directors

BGC Partners, Inc (NASDAQ:BGCP) announces the appointment of Arthur U. Mbanefo to serve as a member of the Board for a term to expire at the 2021 Annual Meeting of Stockholders of the company, or until his successor is duly elected and qualified. Mr Mbanefo was also appointed to the Audit, Compensation, and Environmental, Social and Governance Committees of the Board.

Mr. Mbanefo has been the Chief Investment Officer and Head of Principal Business and Asset Management for ORIX Corporation USA, the U.S. subsidiary of ORIX Corporation, a publicly owned, Tokyo-based international financial services company, since February 2020. In that role, he is responsible for managing the active investment, underwriting and allocation of assets of ORIX Corporation USA and has oversight for all principal business and asset management. In addition, he is responsible for adding new strategies, businesses and assets for ORIX Corporation USA.

Mr Mbanefo previously served as the Managing Partner of Phoenix Merchant Partners LP, a merchant banking and private credit business, from September 2019 until February 2020.

Mr Mbanefo also served as the Chief Investment Officer of Barclays Bank PLC from March 2017 until June 2019 where he was responsible for all the investment of the balance sheet of Barclays Bank PLC across corporate and investment banking, markets, pension and asset management, cards and payments. Prior to this role, he was a Head of Markets at Barclays from September 2015 to February 2017 and a Managing Director at the firm in various market leadership roles from May 2009 to September 2015.

Prior to Barclays, Mr Mbanefo served as Chief Investment Officer and Chief Executive Officer of two alternative investment management firms. In addition, he is an advisory board member of the non-profit, Room to Read, in both London and New York and is a member of the Provost Board of Villanova University.

Mr Mbanefo graduated with a BSc with Honours from Loughborough University.

17,687 Replies to “BGC Partners appoints Arthur Mbanefo to Board of Directors”

  1. It belongs to a family of medications called phosphodiesterase inhibitors, or PDE-5 inhibitors discount cialis Inform patients taking tadalafil tablets not to take other PDE5 inhibitors

  2. buy viagra alternative buy viagra online bingo game buy viagra online and get prescription viagra online viagra buy prescription viagra us pharmacy overnight shipping fedex buy n viagra viagra overnight in usa generic prescription viagra buying viagra in thailand priligy seratonin

  3. A far bigger risk if you re shopping abroad for medications is that you might not get what you paid for and it might not be safe cheapest cialis online Long before the world was dominated by the internet, people were using mail-order pharmacies to obtain low-cost medications

  4. K Holli, J Isola, J Cuzick Low biologic aggressiveness in breast cancer in women using hormone replacement therapy J Clin Oncol 16 3115 3120, 1998 Link, Google Scholar 24 tamoxifen warnings In one embodiment, two or more steviol glycoside solubility enhancers and two or more steviol glycosides, including but not limited to rebaudioside M, rebaudioside D, rebaudioside A and or rebaudioside B, are in a sweetener composition

  5. levitra generic lansoprazole 30 mg Local government officials running the private sector systemin some provinces have also taken to emptying the personalaccounts of contributors to meet obligations to currentretirees clomiphene citrate 50 mg men 18 p for interaction 0

  6. No videos on this search were created nor supported by poison control centers stromectol price in india Zhongguo Zhong Yao Za Zhi 2007 Dec; 32 24 2623 7 Wu et al Inhibitory effects of ethyl acetate extract of Cordyceps sinensis mycelium on various cancer cells in culture and B16 melanoma in C57BL 6 mice